id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
dpc-4642	Zafiriou, Efterpi; Karampinis, Emmanouil; Papadopoulos, Vasileios ; Stefani, Georgia ; Kotsakis, Athanasios ; Vassilopoulos, George 	Non-Melanoma Skin Cancer Aggravation in Polycythemia Vera: Triggered by Ruxolitinib and Silenced With an IFN/Cemiplimab	2025	2	.pdf	application/pdf	624	42	45	Patient undergoing ruxolitinib treatment exhibited SCC progression, manifesting as a significant, ulcerated lesion on the nose tip, draining pus. Due to the additive therapeutic effectiveness of Interferon (IFN) and PD-1/PD-L1 inhibition across various cancer types and in particular in melanoma, anti-PD-1 treatment such as cemiplimab was considered as an additional treatment for this locally advanced and recurrent SCC [2].	cache/dpc-4642.pdf	txt/dpc-4642.txt